Brandon L Pierce

Assistant Professor

University of Chicago
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (14)

Year:

2025

Supplementary Figure S1 shows the results of a Principal Component Analysis of participant SNP genotypes, demonstrating separate clusters of those with African American and European American ancestry.

Year:

2025

Background: African American (AA) men are at increased risk of prostate cancer compared with European American (EA) men. Biological mechanisms, including epigenetics, likely contribute to this disparity, but prior studies have been limited by sample size, candidate gene approaches, or lack of epigenome-wide DNA methylation (DNAm) data. Methods: To improve our understanding of these mechanisms, we compared DNAm features distinguishing tumor and paired histologically benign tissue from 76 AA and 75 EA patients with prostate cancer. We generated genome-wide array-based DNAm data and conducted differential methylation analyses comparing tumor and benign tissues in each ancestry group. We then examined the predictive ability of our identified sites and differential methylation by ancestry group. Results: We identified 90,747 and 98,929 differentially methylated CpGs in AA and EA, respectively, with 76,400 common to both groups. We identified 6,267 genes with differentially methylated promoters common to both ancestries and 639 and 1,301 genes unique to AA and EA respectively, as well as differentially methylated pathways. Only 10 CpGs were needed to distinguish tumor from benign based on a receiver operating characteristic curve (AUC > 0.9), with differentially methylated CpGs in one ancestry accurately predicting tumor versus benign in the other group. We also identified ancestry-associated CpGs (89 in tumor, 423 in benign). Conclusions: Methylation features distinguishing tumor and benign were similar for EA and AA men; however, subtle differences were identified. Impact: Differences in tumor and ancestry-associated CpGs may reveal differential tumor growth strategies, an important area for future disparities research.

Year:

2025

Supplementary Figure S6 shows the distribution of differentially methylated CpGs across the genome in African Americans and European Americans compared with the overall probe distribution of the tested EPIC array CpGs.

Year:

2025

Supplementary Figure S4 shows the distribution of the post-QC CpGs across EPIC Infinium I and Infinium II assays, chromosomes, and genomic regions including CpG islands and transcription start sites.

Year:

2025

Supplementary Table S1 shows the percent variance explained by first 10 Principle Component obtaining through a non-scaled Principle Components Analysis of 683,694 CpGs from 76 African American and 75 European American prostate cancer patients.

Year:

2025

Supplementary Figure S2 shows a Principal Component Analysis of DNA methylation in the benign and tumor tissue of African American and European American individuals, demonstrating tissue type as the largest source of variation (A&B). Additionally, it shows that within tumor samples PC1 is associated with Gleason Score (C).

Year:

2025

Supplementary Table S12 shows the distribution of hyper-methylated, differentially methylated CpGs between European American and African American ancestry groups by genomic location in tumor and benign tissue

Year:

2025

Supplementary Figure S9 shows the similar relationship between tumor and benign tissue in African American and European American men as well as the presence of ancestry-associated CpGs in both tumor and benign tissue.

Year:

2025

Supplementary Figure S3 shows a Principal Component Analysis of DNA methylation in tumor tissue of African Americans and European Americans and demonstrates an association between PC1 and Gleason Score.

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2022

Collaborators (11)

Joseph Lachance

Associate Professor

Georgia Institute of Technology

UNITED STATES
View details

Robert Klein

Associate Professor

Icahn School of Medicine at Mount Sinai

UNITED STATES
View details

Rebecca Graff

Associate Professor

University of California, San Francisco

UNITED STATES
View details

Anthony Williams

Assistant Professor

Washington University in St. Louis

UNITED STATES
View details

Mitchell Machiela

Senior Investigator

National Cancer Institute

UNITED STATES
View details

Ravi Madduri

Senior Scientist

Argonne National Laboratory

UNITED STATES
View details

Lin Chen

Associate Professor

University of Chicago

UNITED STATES
View details

Gladell P. Paner

University of Chicago Medicine

UNITED STATES
View details

Wenlong Chen

Senior Researcher

University of Witwatersrand

SOUTH AFRICA
View details

Donald J Vander Griend

Professor

University of Illinois Chicago (UIC)

UNITED STATES
View details

Russell Z. Szmulewitz

Associate Professor

University of Chicago

UNITED STATES
View details